NCT06752460View on ClinicalTrials.gov

Evaluation of the EF192B Protection Versus No Treatment

NANot yet recruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Skin LesionsSkin Care
Interventions
DEVICE

EF192B

EF192B will be applied after the tape strriping procedure and will be reapplied after 12 hours.

Trial Locations (1)

06696-000

Eurofarma Laboratórios S.A, Itapevi

Sponsors
All Listed Sponsors
lead

Eurofarma Laboratorios S.A.

INDUSTRY